Skeletal changes and growth in experimental uremia
- PMID: 194169
- DOI: 10.1159/000180845
Skeletal changes and growth in experimental uremia
Abstract
Longitudinal growth; bone and growth zone histology; growth cartilage and bone mineralization (tetracycline technique); bone Ca content (neutron activation analysis); bone radiology; serum and urine chemistry; urinary cAMP and serum 25-OH-vitamin D3 were studied in a long-term model of experimental uremia in the rat. Uremia was induced by two-stage subtotal nephrectomy with irradiation of the remaining parenchyma. Ccr in the experimental group was 113 +/- 5.8 micron1/min X 100 g (19.8% of controls) and serum creatinine 1.67 +/- 0.04 mg% (5.1 X control value). Uremic animals were pair-fed with sham-operated controls. In the proximal tibia delayed transformation of cartilage into primary spongiosa with appearance of chondro-osteoid and delayed transformation of primary spongiosa into secondary spongiosa was observed (rickets). Increased amounts of osteoid were present although 25-OH-vitamin D3-levels were high. There were only modest signs of secondary hyperparathyroidism (osteoclast counts; urinary cAMP). In spite of the presence of bone disease, longitudinal growth was not reduced in uremic animals as compared with pair-fed sham-operated animals, but was significantly reduced as compared with ad lib fed control animals. In contrast, weight gain was significantly diminished in uremic animals as compared with pair-fed sham-operated control animals. It is concluded that diminished intake of food is the major determinant of growth retardation in preterminal experimental renal failure.
Similar articles
-
Skeletal growth in uremia.Adv Exp Med Biol. 1977;81:515-31. doi: 10.1007/978-1-4613-4217-5_51. Adv Exp Med Biol. 1977. PMID: 409107
-
Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.J Bone Miner Res. 1987 Dec;2(6):533-45. doi: 10.1002/jbmr.5650020610. J Bone Miner Res. 1987. PMID: 3502683
-
Bone cell kinetics and function during experimental uremia.Metab Bone Dis Relat Res. 1981;3(3):191-8. doi: 10.1016/0221-8747(81)90008-4. Metab Bone Dis Relat Res. 1981. PMID: 7347796
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Skeletal growth in experimental uremia.Kidney Int Suppl. 1983 Nov;15:S53-62. Kidney Int Suppl. 1983. PMID: 6368950 Review.
Cited by
-
Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.Paediatr Drugs. 2003;5(11):763-76. doi: 10.2165/00148581-200305110-00005. Paediatr Drugs. 2003. PMID: 14580225 Review.
-
Alterations of the growth plate in chronic renal failure.Pediatr Nephrol. 2005 Mar;20(3):330-4. doi: 10.1007/s00467-004-1652-4. Epub 2004 Nov 10. Pediatr Nephrol. 2005. PMID: 15549411 Review.
-
Growth plate height of uremic rats is influenced by severity and duration of renal failure.Pediatr Nephrol. 2004 Feb;19(2):187-92. doi: 10.1007/s00467-003-1326-7. Epub 2003 Dec 16. Pediatr Nephrol. 2004. PMID: 14677056
-
A quantitative histologic analysis of the growing long bone metaphysis.Calcif Tissue Int. 1980;32(2):113-22. doi: 10.1007/BF02408530. Calcif Tissue Int. 1980. PMID: 6773628
-
Growth plate alterations in chronic kidney disease.Pediatr Nephrol. 2020 Mar;35(3):367-374. doi: 10.1007/s00467-018-4160-7. Epub 2018 Dec 14. Pediatr Nephrol. 2020. PMID: 30552565 Review.